Filtered By:
Vaccination: Vaccines
Countries: Canada Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2706 results found since Jan 2013.
A postpartum intervention for vaccination promotion by midwives using motivational interviews reduces mothers' vaccine hesitancy, south-eastern France, 2021 to 2022: a randomised controlled trial
ConclusionsOur results show positive effects of MI intervention, and means of its implementation should be investigated in France.PMID:37733238 | DOI:10.2807/1560-7917.ES.2023.28.38.2200819
Source: Euro Surveill - September 21, 2023 Category: Infectious Diseases Authors: Pierre Verger Chlo é Cogordan Lisa Fressard Virginie Gosselin Xavier Donato Magalie Biferi Val érie Verlomme Pierre Sonnier Herv é Meur Philippe Malfait Patrick Berthiaume Lauriane Ramalli Arnaud Gagneur Source Type: research
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
CONCLUSIONS: Adjusting for frailty, aTIV showed statistically significantly better protection than naTIV against influenza-associated hospitalizations in older adults. In future studies, it is important to consider frailty as a significant confounder of VE.PMID:37696717 | DOI:10.1016/j.vaccine.2023.08.070
Source: Vaccine - September 11, 2023 Category: Allergy & Immunology Authors: Henrique Pott Melissa K Andrew Zachary Shaffelburg Michaela K Nichols Lingyun Ye May ElSherif Todd F Hatchette Jason LeBlanc Ardith Ambrose Guy Boivin William Bowie Jennie Johnstone Kevin Katz Phillipe Lagac é-Wiens Mark Loeb Anne McCarthy Allison McGeer Source Type: research
Factors associated with intention for revaccination among patients with adverse events following immunization
CONCLUSION: Physicians appear to use AEFI type and impact to guide recommendations while patients use primarily AEFI impact to form intentions for revaccination. The findings may help inform counselling for patients with AEFIs.PMID:37666696 | DOI:10.1016/j.vaccine.2023.08.067
Source: Vaccine - September 4, 2023 Category: Allergy & Immunology Authors: Caroline E Mu ñoz Anne Pham-Huy Jeffrey M Pernica Fran çois D Boucher Gaston De Serres Wendy Vaudry Cora Constantinescu Manish Sadarangani Julie A Bettinger Bruce Tapi éro Shaun K Morris Athena McConnell Francisco Noya Scott A Halperin Karina A Top Can Source Type: research
Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
This study provides insights into the design of future CMV vaccine efficacy trials, particularly for the identification of CMV infection using molecular assays.FUNDING: Merck Sharp & Dohme, a subsidiary of Merck & Co, Rahway, NJ, USA (MSD).PMID:37660711 | DOI:10.1016/S1473-3099(23)00343-2
Source: Herpes - September 3, 2023 Category: Infectious Diseases Authors: Rituparna Das Daniel Bl ázquez-Gamero David I Bernstein Soren Gantt Oliver Bautista Karen Beck Anthony Conlon Daniel I S Rosenbloom Dai Wang Michael Ritter Beth Arnold Paula Annunziato Kevin L Russell V160-002 study group Source Type: research
Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses
Neonatal Netw. 2023 Aug 1;42(5):291-302. doi: 10.1891/NN-2023-0005.ABSTRACTRespiratory syncytial virus (RSV) is a leading cause of morbidity and hospitalization in young children, and prevention is the primary management strategy. At present, palivizumab, a monoclonal antibody providing immediate passive immunity, rather than a vaccine that induces active immunity, is the only preventive intervention used in routine practice internationally. In Canada, access varies across the country. Prophylaxis policies are mainly driven by cost-effectiveness analyses, and it is crucial that the full costs and benefits of any interventi...
Source: Neonatal Network - September 1, 2023 Category: Perinatology & Neonatology Authors: Marianne Bracht Barry Rodgers-Gray Fabiana Bacchini Bosco A Paes Source Type: research
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
Vaccine. 2023 Aug 30:S0264-410X(23)00991-X. doi: 10.1016/j.vaccine.2023.08.048. Online ahead of print.ABSTRACTThe COVID-19 pandemic has challenged traditional vaccine guidance infrastructure and frameworks, and added urgency and complexity to the operation of National Immunization Technical Advisory Groups (NITAGs). Canada's National Advisory Committee on Immunization (NACI) provides immunization guidance to the Public Health Agency of Canada (PHAC) who publicly shares expert and evidence-informed guidance with Canadian provinces and territories. Throughout the pandemic, NACI and PHAC implemented many adaptations to meet u...
Source: Vaccine - September 1, 2023 Category: Allergy & Immunology Authors: Matthew Tunis Shelley Deeks Robyn Harrison Caroline Quach Shainoor Ismail Marina Salvadori Bryna Warshawsky Kelsey Young Christine Mauviel Erin Henry Source Type: research
Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses
Neonatal Netw. 2023 Aug 1;42(5):291-302. doi: 10.1891/NN-2023-0005.ABSTRACTRespiratory syncytial virus (RSV) is a leading cause of morbidity and hospitalization in young children, and prevention is the primary management strategy. At present, palivizumab, a monoclonal antibody providing immediate passive immunity, rather than a vaccine that induces active immunity, is the only preventive intervention used in routine practice internationally. In Canada, access varies across the country. Prophylaxis policies are mainly driven by cost-effectiveness analyses, and it is crucial that the full costs and benefits of any interventi...
Source: Neonatal Network - September 1, 2023 Category: Perinatology & Neonatology Authors: Marianne Bracht Barry Rodgers-Gray Fabiana Bacchini Bosco A Paes Source Type: research
Canada's National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic
Vaccine. 2023 Aug 30:S0264-410X(23)00991-X. doi: 10.1016/j.vaccine.2023.08.048. Online ahead of print.ABSTRACTThe COVID-19 pandemic has challenged traditional vaccine guidance infrastructure and frameworks, and added urgency and complexity to the operation of National Immunization Technical Advisory Groups (NITAGs). Canada's National Advisory Committee on Immunization (NACI) provides immunization guidance to the Public Health Agency of Canada (PHAC) who publicly shares expert and evidence-informed guidance with Canadian provinces and territories. Throughout the pandemic, NACI and PHAC implemented many adaptations to meet u...
Source: Vaccine - September 1, 2023 Category: Allergy & Immunology Authors: Matthew Tunis Shelley Deeks Robyn Harrison Caroline Quach Shainoor Ismail Marina Salvadori Bryna Warshawsky Kelsey Young Christine Mauviel Erin Henry Source Type: research
Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses
Neonatal Netw. 2023 Aug 1;42(5):291-302. doi: 10.1891/NN-2023-0005.ABSTRACTRespiratory syncytial virus (RSV) is a leading cause of morbidity and hospitalization in young children, and prevention is the primary management strategy. At present, palivizumab, a monoclonal antibody providing immediate passive immunity, rather than a vaccine that induces active immunity, is the only preventive intervention used in routine practice internationally. In Canada, access varies across the country. Prophylaxis policies are mainly driven by cost-effectiveness analyses, and it is crucial that the full costs and benefits of any interventi...
Source: Neonatal Network - September 1, 2023 Category: Perinatology & Neonatology Authors: Marianne Bracht Barry Rodgers-Gray Fabiana Bacchini Bosco A Paes Source Type: research
